The European Commission has approved SIFI's Akantior as the first therapy anywhere in the world for acanthamoeba keratitis (AK), an ultra-rare parasitic infection that can lead to blindness.
2013;39(2):158-161. Patient compliance with proper hygiene techniques is critically important for reducing contact lens–related Acanthamoeba spp infection. [2] Perhaps more critical is an ...
Approval has been granted by the European Commission for the first treatment for adults and children from 12 years of age living with acanthamoeba keratitis. The drug, Akantior, was approved after 15 ...
Swimming or showering while wearing contact lenses can raise a person’s risk of developing Acanthamoeba keratitis, a rare but serious eye infection. Since contact lens wearers are at a higher ...